Neptune Wellness Solutions Inc NEPT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Neptune Wellness Announces Receipt of Nasdaq Delisting Notice and Intention to Appeal
-
Neptune Wellness Nutraceutical Brand, Biodroga, Announces Accounts Receivable Factoring Facility of Up to $8 Million
-
Neptune Wellness Announces Letter of Intent to Acquire Leading Data-Marketing and Artificial Intelligence Company, Datasys, for Total Potential Consideration of $112 Million
-
Neptune Reports Fiscal Second Quarter 2024 Financial Results
-
Neptune Wellness Announces Completion of Sprout Organic's Debt Equitization
-
Neptune Wellness Announces Repayment of Senior Secured Notes
-
Neptune Wellness Solutions Inc. Closes US$4.5 Million Public Offering
-
Thinking about buying stock in BitNile Metaverse, Neptune Wellness Solutions, Alpha Teknova Inc, MSP Recovery, or TradeUP Acquisition?
Trading Information
- Previous Close Price
- $0.40
- Day Range
- $0.37–0.40
- 52-Week Range
- $0.37–41.60
- Bid/Ask
- $0.37 / $0.38
- Market Cap
- $1.71 Mil
- Volume/Avg
- 18,356 / 814,304
Key Statistics
- Price/Earnings (Normalized)
- 0.06
- Price/Sales
- 0.00
- Dividend Yield
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 71
- Website
- https://www.neptunecorp.com
Valuation
Metric
|
NEPT
|
---|---|
Price/Earnings (Normalized) | 0.06 |
Price/Book Value | — |
Price/Sales | 0.00 |
Price/Cash Flow | — |
Financial Strength
Metric
|
NEPT
|
---|---|
Quick Ratio | 0.19 |
Current Ratio | 0.47 |
Interest Coverage | −9.24 |
Profitability
Metric
|
NEPT
|
---|---|
Return on Assets (Normalized) | −67.43% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −230.40% |
Drug Manufacturers - Specialty & Generic Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Kwzx | $84.8 Bil | |
MKKGY
| Merck KGaA ADR | Dhckc | $66.6 Bil | |
HLN
| Haleon PLC ADR | Hnpqy | $37.8 Bil | |
VTRS
| Viatris Inc | Qbtq | $11.8 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Vyvcy | $11.5 Bil | |
CTLT
| Catalent Inc | Fxggwj | $6.7 Bil | |
PRGO
| Perrigo Co PLC | Grlwq | $4.0 Bil | |
CURLF
| Curaleaf Holdings Inc | Nyqpn | $3.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Nvzhr | $3.0 Bil | |
GTBIF
| Green Thumb Industries Inc | Ntqf | $2.7 Bil |